Does cervical favourability and mode of delivery affect the maternal and perinatal outcome in eclampsia?: a cohort study

Authors

  • Momina Zulfeen Department of Obstetrics and Gynecology, Kasturba Medical College, Manipal, Karnataka, India http://orcid.org/0000-0003-2767-2192
  • Radha Tatapudi Department of Obstetrics and Gynecology, GITAM University, Vizag, Vishakapatnam, India
  • Ravella Sowjanya Department of Obstetrics and Gynecology, Siddhartha Medical College, Vijayawada, Andhra Pradesh, India

DOI:

https://doi.org/10.18203/2320-1770.ijrcog20193530

Keywords:

Eclampsia, Pre-eclampsia, Perinatal outcome, Hypertension, Mode of delivery

Abstract

Background: To study the association between cervical favorability at admission and maternal, perinatal outcome. To study the association between mode of delivery and maternal, perinatal outcome in eclampsia.

Methods: This was a retrospective cohort study carried out in a tertiary hospital. All women (92) admitted with antepartum eclampsia from April 2015 to April 2016, with >32 weeks gestation, reassuring foetal heart and no other complications were included in the study. They were divided into two cohorts delivery, maternal and perinatal outcomes were compared between the two groups.

Results: Group with favourable cervix achieved higher vaginal deliveries. Perinatal mortality and morbidity were significantly higher in patients with unfavourable cervix (mortality 39.6% and 20.5% respectively, p: 0.046: morbidity 25.6% and 7.8% respectively, p: 0.033), more so in vaginal delivery (RR 2.355). However there was no significant difference in maternal morbidity. Higher induction-to-delivery interval was the major contributory factor.

Conclusions: Perinatal outcome was worse in patients with unfavourable cervix at induction. This can be attributed to increased induction to delivery time and vaginal route of delivery. Prolonged induction should be avoided in eclampsia.

References

Maternal mortality in 2005: estimates developed by WHO, UNICEF, UNFPA, and the World Bank. 2007. Available at: https://apps.who.int/iris/bitstream/handle/10665/43807/9789244596210_rus.pdf. Accessed on June 8th, 2019.

Duley L. Pre-eclampsia, eclampsia, andhypertension. Clinical Evidence. 2008;2008:1402.

Which anticonvulsant for women with eclampsia? Evidence from the collaborative eclampsia trial Erratum in: Lancet. 1995;345:1455-63.

Pritchard JA. Pritchard SA. Standardised treatment of 159 consecutive cases of eclampsia. Am J Obstet Gynecol. 1975;123:543-52.

Sibai BM. Diagnosis, prevention and management of eclampsia. Obstet Gynecol. 2005;105:402-10.

World Health Organization. Managing complications in pregnancy and chilbirth: a Guide for Midwives and Doctors. Reprod Health. 2010.

Zwart JJ, Richters A, Ory F, de Vries JI, Bloemenkamp KW, van Roosmalen J. Eclampsia in The Netherlands. Obstet Gynecol. 2008;112:820-7.

Miguil M, Chekairi A. Eclampsia, study of 342 cases. Hypertens Pregnancy. 2008;27:103-11.

Hypertensive disorders in pregnancy. In: Cunningham FG, Leveno KJ, Bloom SL, Hauth JC, Gilstrap LC III, Wenstrom KD,eds. Williams obstetrics. 24th ed. New York; McGraw- Hill; 2014:728-771.

Seal SL, Ghosh D, Kamilya G. Does route of delivery affect maternal and perinatal outcome in women with eclampsia? A randomized controlled pilot study. Am J Obstet Gynecol. 2012;206:484.e1-7.

Igberase GO, Ebeigbe PN. Eclampsia: ten years experience in a rural tertiary hospital in the Niger delta, Nigeria. J Obstet Gynaecol. 2006;26:414-7.

Downloads

Published

2019-07-26

Issue

Section

Original Research Articles